Beneficial Effects of a Combination of Korean Red Ginseng and Highly Active Antiretroviral Therapy in Human Immunodeficiency Virus Type 1-Infected Patients
Authors:
Open Access
- 1 August 2009
- journal article
- Published by American Society for Microbiology in Clinical and Vaccine Immunology
- Vol. 16 (8) , 1127-1131
Abstract
To determine whether Korean red ginseng (KRG) has beneficial effects on human immunodeficiency virus type 1 (HIV-1)-infected patients administered highly active antiretroviral therapy (HAART), we analyzed the CD4 T-cell count, viral load, and resistance mutations to HAART in 46 individuals. Thirteen patients harbored resistance mutations at baseline. The study population was divided into two groups: specifically, a group treated with a combination of HAART plus KRG (23 patients) and a group treated with HAART alone (23 patients). The annual increase in CD4 T-cell count in the combination group was significantly higher than that in the group treated with HAART alone ( P < 0.05). Overall, 21 patients harbored resistance mutations after 3 years of therapy. Following exclusion of 13 patients displaying baseline resistance mutations, 7.1% of patients (1/14) in the combination group and 42.1% (8/19) in the HAART group were identified with resistance mutations. One patient with baseline resistance mutations in the combination group did not display resistance mutations 3 years after HAART therapy. High-level resistance mutations were significantly lower in the combination group than in the group treated with HAART alone. Five patients showed no improvement in viral copy number (26.3% [5/19]) in the combination group and 9 (45.0% [9/20]) showed no improvement in the HAART-only group. Our data support the clinical utility of KRG intake during HAART therapy.Keywords
This publication has 28 references indexed in Scilit:
- High Frequency of Gross Deletions in 5′ LTR /gag and nef Genes in Patients Infected with CRF02_AG of HIV Type 1 Who Survived for Over 20 Years: An Association with Korean Red GinsengAIDS Research and Human Retroviruses, 2009
- Frequent Gross Deletion in the HIV Type 1 nef Gene in Hemophiliacs Treated with Korean Red Ginseng: Inhibition of Detection by Highly Active Antiretroviral TherapyAIDS Research and Human Retroviruses, 2009
- High Frequency of Gross Deletions in the 5′ LTR and gag Regions in HIV Type 1-Infected Long-Term Survivors Treated with Korean Red GinsengAIDS Research and Human Retroviruses, 2008
- Low Immune Activation despite High Levels of Pathogenic Human Immunodeficiency Virus Type 1 Results in Long-Term Asymptomatic DiseaseJournal of Virology, 2007
- Ginseng and Salviae herbs play a role as immune activators and modulate immune responses during influenza virus infectionVaccine, 2007
- Ginseng modulates the immune response by induction of interleukin‐12 productionAPMIS, 2004
- Natural Polymorphisms of Protease in Protease Inhibitor-Naive HIV-1 Infected Patients in Korea: A Novel L63M in Subtype BAIDS Research and Human Retroviruses, 2003
- Frequency of Mutations Conferring Resistance to Nucleoside Reverse Transcriptase Inhibitors in Human Immunodeficiency Virus Type 1-Infected Patients in KoreaJournal of Clinical Microbiology, 2002
- CD4+T Cell Kinetics and Activation in Human Immunodeficiency Virus–Infected Patients Who Remain Viremic Despite Long‐Term Treatment with Protease Inhibitor–Based TherapyThe Journal of Infectious Diseases, 2002
- Phylogenetic Analysis of Reverse Transcriptase in Antiretroviral Drug-Naive Korean HIV Type 1 PatientsAIDS Research and Human Retroviruses, 2001